/Dexcom%20Inc%20HQ-by%20JHVEPhoto%20via%20Shutterstock.jpg)
With a market cap of about $46.4 billion, DexCom, Inc. (DXCM) is a leading medical device company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Based in San Diego, California, the company designs and develops advanced CGM products to provide real-time glucose data and insights for both patients and healthcare providers.
Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and DexCom fits this criterion perfectly. DexCom is renowned for its market-leading CGM systems like the Dexcom G6 and G7. The company has over 5,000 employees and operates globally with significant revenue from its innovative CGM technology and devices, which support hundreds of thousands of users worldwide.